Generic placeholder image

Coronaviruses

Editor-in-Chief

ISSN (Print): 2666-7967
ISSN (Online): 2666-7975

Case Report

A Case Report on COVID-19 Causing New Onset of Diabetes Even with No History

Author(s): Manisha Vohra, Mohammad Amir, Ian Osoro and Amit Sharma*

Volume 4, Issue 2, 2023

Published on: 22 August, 2023

Article ID: e230623218220 Pages: 3

DOI: 10.2174/2666796704666230623150612

Price: $65

conference banner
Abstract

This case report presents a case of a 51-year-old male patient who was found to be diabetic after recovering from COVID-19. Case Presentation: The patient was admitted to the COVID care center after testing positive for COVID-19 on November 2020. After spending one week in intensive care and ten days in the isolation ward of the COVID care center, he continued to feel multiple side effects. After fifteen days, he began showing signs of recovery and had no fever or other symptoms of COVID-19. The third SARS-Cov-2 RNA by RT-PCR sample test was also found to be negative. He was shifted to a non- COVID hospital when he became stable. For COVID-19, he was treated with supplementary oxygen therapy by keeping his oxygen level at 5L/min with titrating flow rate SpO2 of more than 90%. The hydroxychloroquine 400 mg orally BD for two days, followed by 200 mg orally BD for four days with a combination of azithromycin 500 mg orally OD for five days, was prescribed to him to treat COVID-19. Conclusion: According to the report "New-onset diabetes in COVID-19," published in the New England Journal of Medicine, there is a bidirectional relationship between COVID-19 and diabetes.

[1]
Nassar M, Daoud A, Nso N, et al. Diabetes mellitus and COVID-19: Review Article. Diabetes Metab Syndr 2021; 15(6)
[http://dx.doi.org/10.1016/j.dsx.2021.102268] [PMID: 34562865]
[2]
Di Dalmazi G, Maltoni G, Bongiorno C, et al. Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study. BMJ Open Diabetes Res Care 2020; 8(2): e001664.
[http://dx.doi.org/10.1136/bmjdrc-2020-001664] [PMID: 33115820]
[3]
Rubino F, Amiel SA, Zimmet P, et al. New-onset diabetes in COVID-19. N Engl J Med 2020; 383(8): 789-90.
[http://dx.doi.org/10.1056/NEJMc2018688] [PMID: 32530585]
[4]
Liao YH, Zheng JQ, Zheng CM, Lu KC, Chao YC. Novel molecular evidence related to COVID-19 in patients with diabetes mellitus. J Clin Med 2020; 9(12): 3962.
[http://dx.doi.org/10.3390/jcm9123962] [PMID: 33297431]
[5]
Fignani D, Licata G, Brusco N, et al. SARS-CoV-2 receptor angiotensin I-converting enzyme type 2 (ACE2) is expressed in human pancreatic β-Cells and in the human pancreas microvasculature. Front Endocrinol 2020; 11: 596898.
[http://dx.doi.org/10.3389/fendo.2020.596898] [PMID: 33281748]
[6]
Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004; 203(2): 631-7.
[http://dx.doi.org/10.1002/path.1570] [PMID: 15141377]
[7]
Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 2010; 47(3): 193-9.
[http://dx.doi.org/10.1007/s00592-009-0109-4] [PMID: 19333547]
[8]
Ni W, Yang X, Yang D, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care 2020; 24(1): 422.
[http://dx.doi.org/10.1186/s13054-020-03120-0] [PMID: 32660650]
[9]
Chee YJ, Ng SJH, Yeoh E. Diabetic ketoacidosis precipitated by COVID-19 in a patient with newly diagnosed diabetes mellitus. Diabetes Res Clin Pract 2020; 164: 108166.
[http://dx.doi.org/10.1016/j.diabres.2020.108166] [PMID: 32339533]
[10]
Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A. COVID ‐19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab 2020; 22(10): 1935-41.
[http://dx.doi.org/10.1111/dom.14057] [PMID: 32314455]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy